PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 87 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.91 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,387,000 | +2452.1% | 539,571 | +1743.7% | 2.06% | +1663.2% |
| Q2 2016 | $407,000 | -91.2% | 29,266 | -90.4% | 0.12% | -93.0% |
| Q1 2016 | $4,634,000 | -31.3% | 305,459 | -14.1% | 1.66% | -41.2% |
| Q4 2015 | $6,743,000 | -21.8% | 355,459 | -21.7% | 2.83% | -17.0% |
| Q3 2015 | $8,624,000 | -19.4% | 453,878 | +9.3% | 3.41% | -18.2% |
| Q2 2015 | $10,703,000 | – | 415,338 | – | 4.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |